Sammenlign metoder

	Chou-Talalay-metoden	Isobologramanalyse	Michaelis-Menten-kinetikk	Populasjonsfarmakodynamisk modellering
Fagfelt	Farmakologi	Farmakologi	Farmakologi	Farmakologi
Familie	Process / pipeline	Process / pipeline	Process / pipeline	Process / pipeline
Opprinnelsesår	1983	1926	1913	1992
Opphavsperson	Ting-Chao Chou and Paul Talalay	Salvatore Loewe	Leonor Michaelis and Maud Menten	Lewis Sheiner and Stephen Roush
Type	synergy quantification	synergy quantification	mechanistic model	dose-response modeling
Opprinnelig kilde	Chou, T. C., & Talalay, P. (1983). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22, 27-55.	Loewe, S. (1926). Die Mischtoxizität. Zeitschrift für Experimentelle Pathologie und Therapie, 24, 315-334.	Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369.	Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57.
Alias	CI method, Chou method, median-effect analysis	isobol, combination index, synergy testing	MM kinetics, Michaelis constant, Vmax	PopPD, population PD, hierarchical PD modeling
Relaterte	3	3	2	3
Sammendrag	The Chou-Talalay method is a quantitative framework for analyzing drug interactions, developed by Ting-Chao Chou and Paul Talalay in 1983. It combines median-effect principle with the combination index (CI) to provide rigorous, model-independent assessment of synergistic, additive, or antagonistic drug effects.	Isobologram analysis is a graphical and quantitative method for detecting and classifying drug interactions, developed by Salvatore Loewe in 1926. It uses dose-response data from two drugs applied individually and in combination to determine whether their interaction is additive, synergistic, or antagonistic.	Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics.	Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction.